Back to Search
Start Over
Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients With Cirrhosis.
- Source :
-
The American journal of gastroenterology [Am J Gastroenterol] 2024 Feb 01; Vol. 119 (2), pp. 364-366. Date of Electronic Publication: 2023 Nov 01. - Publication Year :
- 2024
-
Abstract
- Introduction: Hepatic encephalopathy (HE) is prevalent and is associated with increased morbidity and mortality among patients with cirrhosis. On October 1, 2022, a new, specific International Classification of Diseases-10 code for HE, K76.82, was introduced. We aimed to analyze the diagnostic accuracy of K76.82.<br />Methods: Diagnostic performance of K76.82 for HE (sensitivity, specificity, positive predictive ratio, and negative predictive ratio) was evaluated in 2 large health systems compared with lactulose, rifaximin, and K72.90.<br />Results: A total of 2,483 patients were analyzed. The combination term "lactulose or rifaximin" showed the highest sensitivity of >98% while K76.82 demonstrated a specificity of >87% in all cohorts.<br />Discussion: Although K76.82 is promising, the combination term "lactulose or rifaximin" identified patients with HE more accurately.<br /> (Copyright © 2023 by The American College of Gastroenterology.)
- Subjects :
- Humans
Rifaximin therapeutic use
Lactulose therapeutic use
Gastrointestinal Agents therapeutic use
International Classification of Diseases
Drug Therapy, Combination
Liver Cirrhosis complications
Liver Cirrhosis drug therapy
Hepatic Encephalopathy diagnosis
Hepatic Encephalopathy drug therapy
Hepatic Encephalopathy etiology
Rifamycins therapeutic use
Hydroxamic Acids
Subjects
Details
- Language :
- English
- ISSN :
- 1572-0241
- Volume :
- 119
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The American journal of gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- 37830544
- Full Text :
- https://doi.org/10.14309/ajg.0000000000002560